Protective effect of Melothria maderaspatana leaf fraction on electrolytes, catecholamines, endothelial nitric oxide synthase and endothelin-1 peptide in uninephrectomized deoxycorticosterone acetate-salt hypertensive rats

Journal of Natural Medicines

Volumn 66, Issue 3, 2012, Pages 535-543

  Veeramani, Chinnadurai ^a   Al Numair, Khalid S ^a   Chandramohan, Govindasamy ^a   Alsaif, Mohammed A ^a   Pugalendi, Kodukkur Viswanathan ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

DOCA salt; Electrolytes; eNOS; ET 1; Hypertension; Melothria maderaspatana

Indexed keywords

ACETIC ACID ETHYL ESTER; ADRENALIN; ARGININE; CATECHOLAMINE; CHLORIDE; DEOXYCORTICOSTERONE ACETATE; ELECTROLYTE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; MELOTHRIA MADERASPATANA EXTRACT; NITRATE; NITRITE; NORADRENALIN; PLANT EXTRACT; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CHLORIDE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; HYPERTENSION; KIDNEY; MALE; MEDICINAL PLANT; MELOTHRIA MADERASPATANA; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; RAT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UNINEPHRECTOMY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; CATECHOLAMINES; CUCURBITACEAE; DESOXYCORTICOSTERONE; ENDOTHELIN-1; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE TYPE III; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR;

EID: 84863534405     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-011-0621-z     Document Type: Article

References (54)

1. Ogihara T, Matsuzaki M, Matsuoka H, Shimamoto K, Shimada K, Rakugi H (2005) The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design. Hypertens Res 28:331-338
2. Ducceschi VD, Andrea A, Liccardo B, Sarubbi B, Ferrara L, Romano GP, Santangelo L, Iacono A, Cotrufo M (2000) Ventricular tachyarrhythmias following coronary surgery: predisposing factors. Int J Cardiol 73:43-48
3. Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145-H1149
4. Mulsch A, Bassenge E, Busse R (1989) Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedebergs Arch Pharmacol 340:767-770
5. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655
6. Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, Fujino M (1990) Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 167:941-947
7. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F (1990) Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 15:493-496
8. Larivière R, Day R, Schiffrin EL (1993) Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21:916-920
9. Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S (1995) Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate salt induced hypertension. Br J Pharmacol 114:925-930
10. Jayatilaka KAPW, Ira Thabrew M, Perera DJB (1990) Effect of Melothria maderaspatana on carbon tetrachloride induced changes in rat hepatic microsomal drug-metabolizing enzyme activity. J Ethnopharmacol 30:97-105
11. Ramakrishnamacharya CH, Krishanaswamy MR, Bhima Rao R, Viswanathan S (1996) Anti-inflammatory efficacy of Melothria maderaspatana in active rheumatoid arthritis. Clin Rheumatol 12:214-215
12. Balaraman A, Singh J, Dash S, Maity TK (2010) Antihyperglycemic and hypolipidemic effects of Melothria maderaspatana and Coccinia indica in streptozotocin induced diabetes in rats. Saudi Pharm J 18:173-178
13. Hussein ASM, Kingston DGI (1982) Screening of the medicinal plants used in Sudan folk medicine for anti-cancer activity (II). Fitoterapia 53:119-123
14. Veeramani C, Aristatle B, Pushpavalli G, Pugalendi KV (2010) Antihypertensive efficacy of Melothria maderaspatana leaf extract on sham-operated and uninephrectomized DOCA-salt hypertensive rats. J Basic Clin Physiol Pharmacol 21(1):27-41
15. Veeramani C, Al-Numair KS, Chandramohan G, Alsaif MA, Alhamdan AA, Pugalendi KV (2011) Antihypertensive effect of Melothria maderaspatana leaf fractions on DOCA-salt-induced hypertensive rats and identification of compounds by GC-MS analysis. J Nat Med. doi:10.1007/s11418-011-0590-2 (in press)
16. Gowenlock A (1988) Electrolyte and acid base disturbances. In: Varley's practical clinical biochemistry, 6th edn. CRC press, Boca Raton, pp 550-600
17. Zall DM, Fisher D, Garner MD (1956) Photometric determination of chloride in water. Anal Chem 28:1665
18. Murphy JF, Davies DH, Smith CJ (1992) The development of enzyme-linked immunosorbent assays for the catecholamines adrenaline and noradrenaline. J Immunol Met 18:89-98
19. Ishida Y, Fujita T, Arai K (1981) New detection and separation method for amino acid by HPLC. J Chromatogr A 204:143-148
20. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrite and nitrate in biological fluids. Anal Biochem 126:131-138
21. Towbin A, Stahelin T, Gordon J (1979) Electrophoresis transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
22. Hebden RA, Todd ME, Tang C, Gowen B, McNeill JH (1990) Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes mellitus. Am J Physiol 258:RI042-R1050
23. Slayback DL, Watson RR (2006) Bioflavonoids and cardiovascular health: tea, red wine, cocoa, and Pycnogenol. J Eur Nutraceut Assoc 9:16-21 (review)
24. Zibadi S, Larson DF, Watson RR (2007) Flavonoid-rich dietary supplements' influence on heart failure. In: De Meester F, Watson RR(eds) Wild type diet.Humana Press Inc,NewJersey, pp 435-442
25. Suzuki A, Kagawa D, Fujii A, Ochiai R, Tokimitsu I, Saito I (2002) Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens 15:351-357
26. Veeramani C, Aristatile B, Pushpavalli G, Pugalendi KV (2011) Effects of Melothria maderaspatana leaf extract on antioxidant status in sham-operated and uninephrectomized DOCA-salt hypertensive rats. Saudi J Biol Sci 8:99-105
27. Schnackenberg CG, Welch W, Wilcox CS (1999) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 32:59-64
28. Akpaffiong MJ, Taylor AA (1998) Antihypertensive and vasodilator actions of antioxidants in SHR. Am J Hypertens 11: 1450-1460
29. Raja B, Pugalendi KV (2009) Evaluation of antioxidant activity of Melothria maderaspatana in vitro. Cent Eur J Biol 5:224-230
30. Engelhard YN, Gazer B, Paran E (2006) Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 151:1
31. Karppanan H (1991) Minerals and blood pressure. Ann Med 23:299-305
32. Blaustein MP (1984) Sodium and hypertension. Where are we going? Pharmacol Toxicol 54:37-42
33. Leiba A, Vald A, Peleg E, Shamiss A, Grossman E (2005) Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients? Nutrition 21:462-466
34. Moreau P, Drolet G, Yamaguchi N, de Champlain J (1993) Role of presynaptic β2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension. Am J Hypertens 6:1016-1024
35. De Champlain J, Van Amerigen MR (1972) Regulation of blood pressure by sympathetic nerve fibers and adrenal medulla in normotensive and hypertensive rats. Circ Res 31:617-628
36. Naruse M, Naruse K, Demura H (1994) Recent advances in endothelin research on cardiovascular and endocrine systems. Endocr J 41:491-507
37. Kamada Y, Nagaretani H, Tamura S, Ohama T, Maruyama T, Hiraokah H, Matsuzawa Y (2001) Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. J Clin Invest 108:663-664
38. Siani A, Pagano E, Iacone R (2000) Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens 13:547-551
39. Chen PY, Sanders PW (1993) Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22:812-818
40. Schlaich MP, Delles C, Schmieder RE (2007) Investment of endothelial mechanisms in L-arginine induced alterations of renal hemodynamics in humans. J Hypertens 7:1515-1516
41. Linke A, Recchia F, Zhang X, Hintze TH (2003) Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev 8:87-97
42. Perticone F, Ceravolo R, Pujia A (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 4:191-196
43. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
44. Katoh M, Egashira K, Usui M, Ichiki T, Tomita H, Shimokawa H, Rakugi H, Takeshita A (1998) Cardiac angiotensin II receptors are up-regulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res 83:743-751
45. Kojda G, Harrison D (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43:562-571
46. Doggrell SA, Brown L (1998) Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39:89-105
47. Ni J, Oveisi F, Vaziri MD (1999) Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension 34:552-557
48. Saunders PW (1996) Salt-sensitive hypertension: lessons from animal models. Am J Kidney Dis 28:775-782
49. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL (2003) Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodelling. Hypertension 42:49-55
50. Callera GE, Montezano AC, Touyz RM, Zorn TM, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC (2004) ETAreceptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats. Hypertension 43:872-879
51. Kobayashi N, Kobayashi K, Hara K, Higashi T, Yanaka H, Yagi S, Matsuoka H (1999) Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens 12:483-491
52. Touyz RM, Schiffrin EL (2003) Role of endothelin in human hypertension. Can J Physiol Pharmacol 81:533-541
53. Moreland S, McMullen DM, Delaney CL, Lee VG, Hunt JT (1992) Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem Biophys Res Commun 184:100-106
54. Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC (2003) ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42:811-817